Related Experiment Video

Updated: Aug 9, 2026

Using Caenorhabditis elegans for Studying Trans- and Multi-Generational Effects of Toxicants
08:58

Using Caenorhabditis elegans for Studying Trans- and Multi-Generational Effects of Toxicants

Published on: July 29, 2019

Genotoxicity from domestic use of organophosphate pesticides

A D Lieberman1, M R Craven, H A Lewis

  • 1Center for Occupational and Environmental Medicine, North Charleston, South Carolina 29420, USA.

Journal of Occupational and Environmental Medicine
|November 27, 1998
PubMed

Insights

Organophosphate pesticides, used domestically, can cause genotoxic effects, leading to chromosome damage in susceptible individuals. This DNA damage serves as a biomarker for toxic exposure from these hazardous chemicals.

Area of Science:

  • Environmental toxicology
  • Genetics
  • Biomarkers

Background:

  • Organophosphate pesticides are widely used in domestic applications.
  • Exposure to these chemicals can pose health risks.
  • Chromosome damage in peripheral blood can indicate toxic exposure.

Purpose of the Study:

  • To investigate chromosome damage in patients exposed to domestic organophosphate pesticides.
  • To identify chromosome alterations as biomarkers of cumulative toxic exposure.
  • To assess the genotoxic potential of commonly used organophosphate pesticides in domestic settings.

Main Methods:

  • Peripheral blood samples from eight exposed patients were cultured.
  • Chromosomes were photographed to analyze alterations.
  • Types of chromosome damage were cataloged.

Main Results:

  • Observed chromosome alterations included breaks, minutes, dicentrics, rings, translocations, exchanges, and endoreduplications.
  • Genotoxic changes were evident from domestic application of organophosphate pesticides.
  • Findings support the genotoxic effects of organophosphate pesticides at domestic spray levels.

Conclusions:

  • Organophosphate pesticides demonstrate genotoxic effects, causing chromosome damage.
  • Chromosome alterations serve as a biomarker for cumulative toxic exposure.
  • Domestic use of organophosphate pesticides presents potential adverse health effects.

More Related Videos

Determination of the Absorption, Translocation, and Distribution of Imidacloprid in Wheat06:11

Determination of the Absorption, Translocation, and Distribution of Imidacloprid in Wheat

Published on: April 28, 2023

Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants08:22

Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants

Published on: December 22, 2023

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...